Incidental Detection of Pulmonary Lymphangitic Carcinomatosis on F-PSMA 1007 in a Case of Prostate Cancer Without Pulmonary Symptoms.
作者信息
Mahdi Raza Abbas, M Gowtham, Mittal Bhagwant Rai, Singh Harmandeep, Kumar Rajender, Kumar Santosh
机构信息
Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.
出版信息
Nucl Med Mol Imaging. 2025 Jun;59(3):212-213. doi: 10.1007/s13139-024-00904-y. Epub 2025 Jan 9.
Abstract
摘要
相似文献
1
Incidental Detection of Pulmonary Lymphangitic Carcinomatosis on F-PSMA 1007 in a Case of Prostate Cancer Without Pulmonary Symptoms.在一例无肺部症状的前列腺癌患者中，F-PSMA 1007偶然检测到肺淋巴管癌病。
Nucl Med Mol Imaging. 2025 Jun;59(3):212-213. doi: 10.1007/s13139-024-00904-y. Epub 2025 Jan 9.
2
[Ga]Ga-PSMA Versus [F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature.镓-PSMA 与 F-PSMA 正电子发射断层扫描/计算机断层扫描在原发性和复发性前列腺癌分期中的比较。文献系统评价。
Eur Urol Oncol. 2022 Jun;5(3):273-282. doi: 10.1016/j.euo.2022.03.004. Epub 2022 Mar 30.
3
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.阴性前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描能否避免新诊断前列腺癌患者进行盆腔淋巴结清扫？一项以病理组织学为参考标准的系统评价和Meta分析
Eur Urol Oncol. 2022 Feb;5(1):1-17. doi: 10.1016/j.euo.2021.08.001. Epub 2021 Sep 17.
4
Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis.前列腺特异性膜抗原正电子发射断层扫描与常规影像学方法在中高危前列腺癌初始分期中的诊断准确性的头对头比较：系统评价和荟萃分析。
Eur Urol. 2023 Jul;84(1):36-48. doi: 10.1016/j.eururo.2023.03.001. Epub 2023 Apr 7.
5
F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis.F-PSMA-1007 PET 在生化复发前列腺癌中的应用：一项更新的荟萃分析。
Contrast Media Mol Imaging. 2021 Dec 18;2021:3502389. doi: 10.1155/2021/3502389. eCollection 2021.
6
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment.前列腺特异性膜抗原正电子发射断层扫描在前列腺癌明确治疗前诊断和初始分期中作用的综合系统评价与荟萃分析
Eur Urol. 2025 Jun;87(6):654-671. doi: 10.1016/j.eururo.2025.03.003. Epub 2025 Mar 27.
7
Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies.根治性治疗后生化复发前列腺癌男性患者中使用不同配体的PSMA PET检测率：前瞻性研究的系统评价和荟萃分析
Acad Radiol. 2024 Feb;31(2):544-563. doi: 10.1016/j.acra.2023.08.044. Epub 2023 Sep 27.
8
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.基于前列腺特异性膜抗原正电子发射断层扫描靶向活检对临床显著前列腺癌检测的诊断性能：系统评价和荟萃分析。
Eur Urol Oncol. 2022 Aug;5(4):390-400. doi: 10.1016/j.euo.2022.04.006. Epub 2022 Jun 15.
9
Comparison of F-based PSMA radiotracers with [Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis.F 基 PSMA 放射性示踪剂与 [Ga]Ga-PSMA-11 在前列腺癌 PET/CT 成像中的比较：系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2024 Dec;27(4):654-664. doi: 10.1038/s41391-023-00755-2. Epub 2023 Nov 28.
10
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.（18）F/（11）C-胆碱的新临床适应证、正电子发射断层扫描的新型示踪剂和用于前列腺癌分期的有前途的混合设备：文献系统评价。
Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2.
引用本文的文献
1
The Role of [18F]FDG PET Imaging for the Assessment of Pulmonary Lymphangitic Carcinomatosis: A Comprehensive Narrative Literature Review.[18F]氟代脱氧葡萄糖正电子发射断层扫描成像在评估肺淋巴管癌病中的作用：一项全面的叙述性文献综述
Diagnostics (Basel). 2025 Jun 26;15(13):1626. doi: 10.3390/diagnostics15131626.
2
Recurrent pulmonary lymphangitis carcinomatosis detected on Lu-PSMA-617 post-therapy scan in mCRPC with negative PSMA PET and HRCT.在PSMA PET和HRCT均为阴性的mCRPC患者中，经Lu-PSMA-617治疗后扫描发现复发性肺淋巴管癌病。
Eur J Nucl Med Mol Imaging. 2025 Jun 6. doi: 10.1007/s00259-025-07392-y.
本文引用的文献
1
18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer.18F-PSMA-1007在前列腺癌肺淋巴管癌转移灶中的摄取情况
Clin Nucl Med. 2021 Jul 1;46(7):e355-e357. doi: 10.1097/RLU.0000000000003582.
2
Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018.肺淋巴管癌病：1970-2018 年病例报告的系统评价和荟萃分析。
Postgrad Med. 2019 Jun;131(5):309-318. doi: 10.1080/00325481.2019.1595982. Epub 2019 Apr 5.
3
Lymphangitic Carcinomatosis From Prostate Cancer Identified With Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography Imaging.通过镓-68前列腺特异性膜抗原正电子发射断层扫描成像确诊的前列腺癌淋巴管癌病
Urology. 2018 Apr;114:e1-e2. doi: 10.1016/j.urology.2017.12.010. Epub 2017 Dec 29.
4
FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.18F-FDG PET/CT 评估肺淋巴管癌病。
AJR Am J Roentgenol. 2010 Jan;194(1):231-6. doi: 10.2214/AJR.09.3059.
5
Mediastinal metastases from prostatic carcinoma.前列腺癌的纵隔转移
J Urol. 1982 Aug;128(2):331-4. doi: 10.1016/s0022-5347(17)52913-4.
Zotero 插件